Futagawa N, Hasegawa K, Miyahara H, Tanaka H, Tsukahara H
Front Pediatr. 2024; 12:1500023.
PMID: 39698473
PMC: 11653183.
DOI: 10.3389/fped.2024.1500023.
Arundel P, Bishop N
Calcif Tissue Int. 2024; 115(6):812-827.
PMID: 38553634
PMC: 11606989.
DOI: 10.1007/s00223-024-01202-7.
Ward L
Front Endocrinol (Lausanne). 2024; 14:1266986.
PMID: 38374961
PMC: 10875302.
DOI: 10.3389/fendo.2023.1266986.
Meneghetti L, Perry K
JFMS Open Rep. 2023; 9(2):20551169231183752.
PMID: 37581124
PMC: 10423456.
DOI: 10.1177/20551169231183752.
Majdoub F, Ferjani H, Nessib D, Kaffel D, Maatallah K, Hamdi W
Ann Pediatr Endocrinol Metab. 2023; 28(2):98-106.
PMID: 37401056
PMC: 10329944.
DOI: 10.6065/apem.2346058.029.
Brain-Type Creatine Kinase Release from Cultured Osteoclasts Exposed to Neridronate in Children Affected by Osteogenesis Imperfecta Type 1.
Faienza M, Tummolo A, Celli M, Finocchiaro R, Piacente L, Di Serio F
Biomedicines. 2023; 11(2).
PMID: 36830994
PMC: 9953364.
DOI: 10.3390/biomedicines11020458.
Quercetin potentiates the anti-osteoporotic effects of alendronate through modulation of autophagy and apoptosis mechanisms in ovariectomy-induced bone loss rat model.
Mousavi S, Vakili S, Zal F, Savardashtaki A, Jafarinia M, Sabetian S
Mol Biol Rep. 2023; 50(4):3693-3703.
PMID: 36829081
DOI: 10.1007/s11033-023-08311-w.
Alendronate treatment in cats with persistent ionized hypercalcemia: A retrospective cohort study of 20 cases.
Kurtz M, Desquilbet L, Maire J, Da Riz F, Canonne-Guibert M, Benchekroun G
J Vet Intern Med. 2022; 36(6):1921-1930.
PMID: 36181368
PMC: 9708413.
DOI: 10.1111/jvim.16508.
Longitudinal assessment of vascular calcification in generalized arterial calcification of infancy.
Ramirez-Suarez K, Cohen S, Barrera C, Levine M, Goldberg D, Otero H
Pediatr Radiol. 2022; 52(12):2329-2341.
PMID: 35438330
PMC: 10406615.
DOI: 10.1007/s00247-022-05364-0.
Pharmacological Therapies for Osteoporosis: A Bayesian Network Meta-Analysis.
Shen J, Ke Z, Dong S, Lv M, Yuan Y, Song L
Med Sci Monit. 2022; 28:e935491.
PMID: 35430576
PMC: 9022483.
DOI: 10.12659/MSM.935491.
Histomorphometric and microarchitectural analysis of bone in metastatic breast cancer patients.
Beltran-Bless A, Murshed M, Zakikhani M, Kuchuk I, Bouganim N, Robertson S
Bone Rep. 2021; 15:101145.
PMID: 34841014
PMC: 8605385.
DOI: 10.1016/j.bonr.2021.101145.
Bisphosphonate-Based Conjugates and Derivatives as Potential Therapeutic Agents in Osteoporosis, Bone Cancer and Metastatic Bone Cancer.
Mbese Z, Aderibigbe B
Int J Mol Sci. 2021; 22(13).
PMID: 34206757
PMC: 8268474.
DOI: 10.3390/ijms22136869.
Patient-reported effectiveness and safety of Pamidronate in NSAIDs-refractory chronic recurrent multifocal osteomyelitis in children.
Juszczak B, Sulko J
Rheumatol Int. 2021; 42(4):699-706.
PMID: 34018012
PMC: 8940851.
DOI: 10.1007/s00296-021-04886-4.
Ozonated oil effect for prevention of medication-related osteonecrosis of the jaw (MRONJ) in rats undergoing zoledronic acid therapy.
Monteiro C, Vieira E, Emerick C, Azevedo R, Pascoal V, Homsi N
Clin Oral Investig. 2021; 25(12):6653-6659.
PMID: 33895916
DOI: 10.1007/s00784-021-03951-3.
Clinical course in two children with Juvenile Paget's disease during long-term treatment with intravenous bisphosphonates.
Hoppner J, Steff K, Misof B, Schundeln M, Hovel M, Lucke T
Bone Rep. 2021; 14:100762.
PMID: 33850973
PMC: 8039828.
DOI: 10.1016/j.bonr.2021.100762.
Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune-Albright Syndrome.
van der Bruggen W, Vriens D, Meier M, Smit F, Winter E, de Geus-Oei L
J Clin Endocrinol Metab. 2021; 106(8):e2980-e2994.
PMID: 33788944
PMC: 8277209.
DOI: 10.1210/clinem/dgab212.
Substance P blocks ovariectomy-induced bone loss by modulating inflammation and potentiating stem cell function.
Piao J, Park J, Hwang D, Son Y, Hong H
Aging (Albany NY). 2020; 12(20):20753-20777.
PMID: 33109775
PMC: 7655156.
DOI: 10.18632/aging.104008.
Osteoporotic Conditions Influence the Activity of Adipose-Derived Stem Cells.
Park J, Piao J, Park G, Yoo K, Hong H
Tissue Eng Regen Med. 2020; 17(6):875-885.
PMID: 32946062
PMC: 7710784.
DOI: 10.1007/s13770-020-00289-x.
Atypical femoral neck fracture after prolonged bisphosphonate therapy.
Kim K, Park Y, Kim T, Seo K
J Pathol Transl Med. 2020; 54(4):346-350.
PMID: 32586069
PMC: 7385268.
DOI: 10.4132/jptm.2020.05.14.
Early detected femoral neck insufficiency fracture in a patient treated with long-term bisphosphonate therapy for osteoporosis: A need for MRI.
Seong Y, Shin J, Park W
Int J Surg Case Rep. 2020; 70:213-215.
PMID: 32417741
PMC: 7229416.
DOI: 10.1016/j.ijscr.2020.04.003.
